Hormoz Moaven, PhD
Senior Principal, Los Angeles
Hormoz has been a part of Deallus for over 6 years. He is a strong project lead with expertise as a trusted thought partner and industry consultant across many disease areas. During his time with Deallus, Hormoz has successfully facilitated strategic and tactical engagements involving new product planning, clinical development, product launch, market landscaping, competitive benchmarking, patient support, digital technology integration, and market access. He has also supported a breadth of project scopes, including global initiatives focused on life cycle management, commercial opportunity assessment, generic entry scenario planning, biologic manufacturing, KOL/payer perspectives, companion diagnostics, and biosimilars.
What do you bring to Deallus and clients that is unique?
I have a very client-centric approach and my work ethic stems from that – I put the client first in everything I do. I also have a very curious mind – I want to find more information and don’t stop until I do.
So I tend to uncover some very interesting insights where other people might have stopped sooner, before they find that insight that changes your view on something. I’m really scientifically driven and I think it shows in this aspect of my personality. I need to get to the ‘why’ of something.

Background and experience
6+ years of life sciences consulting experience
Worked with 5 of top 20 pharma, specializing in opportunity and threat assessment
Therapy area expertise
Oncology
Neuroscience
Rare Diseases
Ophthalmology
Inflammation and Immunology
Biosimilars
Generics
Cardiovascular
Respiratory
Life outside of work
Family is really important to me. I’m lucky enough to have a beautiful wife and two amazing daughters – one is five and the other is 18 months, so as you can imagine they take up the majority of my time. Since becoming a father I haven’t focused much on my other hobbies outside work, like going to films with friends and live concerts. But I’m not complaining – they are absolutely worth it.